Cargando…
Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis
TMZ resistance remains one of the main reasons why treatment of glioblastoma (GBM) fails. In order to investigate the underlying proteins and pathways associated with TMZ resistance, we conducted a cytoplasmic proteome research of U87 cells treated with TMZ for 1 week, followed by differentially exp...
Autores principales: | Yi, Guo-zhong, Xiang, Wei, Feng, Wen-yan, Chen, Zi-yang, Li, Yao-min, Deng, Sheng-ze, Guo, Man-lan, Zhao, Liang, Sun, Xue-gang, He, Min-yi, Qi, Song-tao, Liu, Ya-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852899/ https://www.ncbi.nlm.nih.gov/pubmed/29687002 http://dx.doi.org/10.1155/2018/5238760 |
Ejemplares similares
-
Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis
por: Li, Lei, et al.
Publicado: (2019) -
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017) -
Prediction and Analysis of Key Genes in Glioblastoma Based on Bioinformatics
por: Long, Hao, et al.
Publicado: (2017) -
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023) -
Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways
por: Zhang, Jinming, et al.
Publicado: (2019)